1147PEVEROLIMUS (EVE) TREATMENT FOR ADVANCED G1-G2 NEUROENDOCRINE TUMOURS (NETS) IN THE COMMUNITY SETTING: CLINICAL BENEFIT IRRESPECTIVE OF GRADE OR PRIMARY TUMOUR SITE
Custodio,, Jimenez Fonseca, P., Alonso-Orduna, V., López, C., Alonso Gordoa, T., Crespo, G., Carmona-Bayonas, A., Álvarez-Escolá, C., Polo, E., Mangas, M., Herrera Gómez, R.G., Solís Hernández, M.D.PVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu345.16
Date:
September, 2014
File:
PDF, 65 KB
2014